Our data showed that PRKAR1A deletion increased the proliferation and migration of lung adenocarcinoma cells and that decreased levels of PRKAR1A led E-cadherin upregulation to reasonably conjecture that PRKAR1A was an anti-oncogene in the lung. The gene discussed is PRKAR1A; the disease is lung adenocarcinoma.